Inventor
CHEN FENG-JING
US27 patents
⚠️ This page may combine multiple inventors who share the name “CHEN FENG-JING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIPOCINE INC
14 patentsUS7374779B2May 20, 2008
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
LIPOCINE INC332 citations99
US6923988B2Aug 2, 2005
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
LIPOCINE INC857 citations99
US6720001B2Apr 13, 2004
Emulsion compositions for polyfunctional active ingredients
LIPOCINE INC469 citations99
US6569463B2May 27, 2003
Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions
LIPOCINE INC941 citations99
US6468559B1Oct 22, 2002
Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
LIPOCINE INC169 citations99
US6451339B2Sep 17, 2002
Compositions and methods for improved delivery of hydrophobic agents
LIPOCINE INC514 citations99
US6383471B1May 7, 2002
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
LIPOCINE INC1,013 citations99
US6309663B1Oct 30, 2001
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
LIPOCINE INC561 citations99
US6294192B1Sep 25, 2001
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
LIPOCINE INC929 citations99
US6267985B1Jul 31, 2001
Clear oil-containing pharmaceutical compositions
LIPOCINE INC746 citations99
US6248363B1Jun 19, 2001
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
LIPOCINE INC1,826 citations99
US6982281B1Jan 3, 2006
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
LIPOCINE INC96 citations98
US6761903B2Jul 13, 2004
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
LIPOCINE INC305 citations97
US6458383B2Oct 1, 2002
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
LIPOCINE INC139 citations96
EPALEX CORP
6 patentsUS11207334B1Dec 28, 2021
Fospropofol formulations
EPALEX CORP9 citations85
US11628178B2Apr 18, 2023
Fospropofol methods and compositions
EPALEX CORP6 citations80
US11478490B1Oct 25, 2022
Fospropofol formulations
EPALEX CORP3 citations72
US11439653B1Sep 13, 2022
Fospropofol formulations
EPALEX CORP2 citations72
US12397006B2Aug 26, 2025
Fospropofol formulations
EPALEX CORP0 citations62
US12377110B2Aug 5, 2025
Fospropofol methods and compositions
EPALEX CORP0 citations57
EAGLE PHARMACEUTICALS INC
5 patentsUS11590077B2Feb 28, 2023
Fulvestrant formulations and methods of their use
EAGLE PHARMACEUTICALS INC2 citations68
US12115164B2Oct 15, 2024
Pemetrexed formulations
EAGLE PHARMACEUTICALS INC0 citations62
US11793813B2Oct 24, 2023
Pemetrexed formulations
EAGLE PHARMACEUTICALS INC0 citations62
US12186427B2Jan 7, 2025
Fulvestrant formulations and methods of their use
EAGLE PHARMACEUTICALS INC0 citations58
US12370199B2Jul 29, 2025
Fulvestrant formulations and methods of their use
EAGLE PHARMACEUTICALS INC0 citations50